Has Osita Onugha, MD received payments from drug or device companies?

Yes. Drug and device makers reported $52,323 in general payments to Osita Onugha, MD across 146 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Osita Onugha, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Osita Onugha, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Osita Onugha, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Culver City, CANPI 1164600128

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Atricure, Inc. at 41.7% of the total. Reporting peaked in 2024 at $17,890 and has fallen 93.1% since, to $1,228 in 2025.

$52,323in general payments, 2019–2025

Across 146 payments — averaging $358.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Atricure, Inc.$22K
Acumed LLC$7K
Intuitive Surgical$7K
Kls-martin L.p.$5K
Medtronic$4K
AstraZeneca$2K
plus $6K from 18 others

What the payments were for

Consulting fees$27,43652%
Speaking & faculty fees$8,70017%
Travel & lodging$5,31310%
Food & beverage$6,76313%
Education$4,1118%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Atricure, Inc.	20	$21,803
Acumed LLC	12	$6,817
Intuitive Surgical	18	$6,801
Kls-martin L.p.	8	$4,757
Medtronic	9	$4,158
AstraZeneca	2	$1,888
Johnson & Johnson(2 entities)	23	$1,396
Pinnacle Biologics, Inc	9	$1,339
Medical Device Business Services, Inc.	8	$833
Covidien LP	7	$535
BD	2	$303
Zimmer Biomet	4	$274
On Target Laboratories, Inc	1	$240
Boston Scientific	2	$213
Davol Inc.	2	$204
Baxter Healthcare	5	$197
E.r. Squibb & Sons, L.L.C.	5	$148
Merck	2	$131
KARL Storz Endoscopy-america	1	$113
Veran Medical Technologies, Inc.	1	$49
Otsuka America Pharmaceutical, Inc.	2	$48
KCI USA, Inc.	1	$27
Chiesi USA, Inc.	1	$24
Angiodynamics, Inc.	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$10,035
ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$9,751
RibLoc$6,638
DAVINCI XI$4,000
Da Vinci Surgical System$2,416
IMFINZI$1,860
ATRICURE CRYOSURGICAL SYSTEM$1,500
Photofrin$1,200
MATRIXRIB$407
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$280
NA$268
superDimension$267
Cytalux$240
XCM Biologic Tissue Matrix$230
ORISE$193
SYNERGY ABLATION SYSTEM$174
Progel Applicator Spray Tips$157
Signet$154
PROGEL$143
Pectus Bar$126

How this compares

$52,323 in reported general payments places this provider in the 85th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California →

Medicare billing

Part B allowed, 2024

$64,047

Medicare patients

Services billed

226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Culver City

Thomas FogartyPortola Valley$3.7M
Steven GundryPalm Springs$1.6M
Armin KiankhooySaint Helena$941K
Ara KlijianMurrieta$916K
Gregory FontanaThousand Oaks$875K
Gansevoort DunningtonSaint Helena$764K
Wilson TsaiWalnut Creek$680K
Fernando FleischmanLos Angeles$608K
Harmik SoukiasianLos Angeles$577K
Ali KhoynezhadLong Beach$476K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →